EC-T
Showing 1 - 25 of >10,000
Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)
Recruiting
- Hormone Receptor Positive HER-2 Negative Breast Cancer
- Docetaxel
- +3 more
-
Shanghai, Shanghai, ChinaBreast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023
Platelet Aggregation, Type 2 Diabetes, Aspirin Trial in Montréal (Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew
Not yet recruiting
- Platelet Aggregation
- +4 more
- Aspirin 81Mg Ec Tab twice daily for 7 days
- +2 more
-
Montréal, Quebec, CanadaMontreal Heart Institute
Jan 25, 2023
Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,
Not yet recruiting
- Prostate Carcinoma
- +3 more
- Bendamustine
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2023
Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Metastatic Colorectal Adenocarcinoma
- +5 more
- Bendamustine
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 12, 2023
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Breast Cancer Trial in Beijing (EC-T, TP)
Completed
- Breast Cancer
- EC-T
- TP
-
Beijing, ChinaCancer Institute & Hospital Chinese Academy of Medical Sciences
Feb 5, 2021
Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Triple Negative Breast Cancer
- Aldesleukin
- +12 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 9, 2023
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial
Not yet recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +5 more
- Interferon Beta-1A
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
Diabetes, Type 2 Trial in Montréal (Aspirin 80 mg EC Tab)
Recruiting
- Diabetes Mellitus, Type 2
- Aspirin 80 mg EC Tab
-
Montréal, Quebec, CanadaMontreal Heart Institute
Nov 2, 2021
Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom
Active, not recruiting
- Triple Negative Metastatic Breast Cancer
- +3 more
- KU-0059436 (AZD2281)(PARP inhibitor)
- +3 more
-
Brussels, Belgium
- +3 more
Dec 19, 2022
Breast Cancer Invasive Trial in Shanghai (Pyrotinib, Trastuzumab, Pertuzumab)
Active, not recruiting
- Breast Cancer Invasive
- Pyrotinib
- +7 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Bone Marrow Aspiration
- +10 more
-
Los Angeles, CaliforniaMelanie Ayala Ceja
Jul 10, 2023
Breast Cancer Trial in Shanghai (Paclitaxel, Carboplatin, Epirubicin)
Recruiting
- Breast Cancer
- Paclitaxel
- +6 more
-
Shanghai, Shanghai, ChinaCancer Hospital Affiliated to Fudan University
Mar 5, 2020
Anal Dysplasia, Human Papillomavirus, Anal Cancer Trial in Vancouver, Ottawa, Toronto (The Hyfrecator ® 2000 Electrosurgical
Terminated
- Anal Dysplasia
- +2 more
- The Hyfrecator ® 2000 Electrosurgical System
- Observation Alone
-
Vancouver, British Columbia, Canada
- +3 more
Jun 9, 2022
Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- AZD4547
- +6 more
-
Los Angeles, California
- +26 more
Oct 17, 2022
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +4 more
-
West Hollywood, California
- +101 more
Jan 16, 2023
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
Urothelial Carcinoma Trial in United States (disitamab vedotin, pembrolizumab)
Recruiting
- Urothelial Carcinoma
- disitamab vedotin
- pembrolizumab
-
Los Angeles, California
- +17 more
Jan 3, 2023
Smoking Cessation, Electronic Cigarette Use Trial in Islamabad (Electronic Cigarette (EC), Nicotine Replacement Therapy)
Not yet recruiting
- Smoking Cessation
- Electronic Cigarette Use
- Electronic Cigarette (EC)
- Nicotine Replacement Therapy
-
Islamabad, PakistanHealth Research Consulting
Sep 26, 2023
Choroideremia, X-Linked Retinitis Pigmentosa Trial in Worldwide (BIIB111, BIIB112)
Enrolling by invitation
- Choroideremia
- X-Linked Retinitis Pigmentosa
- BIIB111
- BIIB112
-
Los Angeles, California
- +22 more
Apr 20, 2022
Ergonomics Trial in Odense (Ergonomic chinrest used with low shoulder rest (EC))
Completed
- Ergonomics
- Ergonomic chinrest used with low shoulder rest (EC)
-
Odense, DenmarkUniversity of Southern Denmark
Nov 7, 2022
Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)
Active, not recruiting
- Aortic Valve Disease
- Aortic Valve Disorder
- Trifecta GT (Glide Technology) Valve
-
Rochester, Minnesota
- +26 more
Mar 10, 2022
Breast Tumor Trial in China (Epirubicin plus Cyclophosphamide, Taxanes, Taxanes plus Carboplatin)
Recruiting
- Breast Neoplasm
- Epirubicin plus Cyclophosphamide
- +2 more
-
Fuding, Fujian, China
- +26 more
Mar 28, 2022